Review about EVER webinar 'Cerebroylsin's evidence from TBI research'

Treating secondary damage symptoms occurring short-and longterm after neurotrauma is an essential task of critical care pecialists working in the ER and ICU. Pharmacological agents indicated to save lives after polytrauma or isolated head trauma are globally accepted medications. Cerebrolysin^® can nowadays be included into these globally acknowledged treatment bundles due to
the strong evidence provided from the CAPTAIN trials.

In a webinar in April, Dr. Pfausler, Dr. Widhalm and Dr. Bayley discussed how the evidence lead to the inclusion into hospital-internal standard treatment strategies as well as first acknowledgement in important guidelines.

Please find all details in the report below.

The full recording of the event can you find here.